STOCK TITAN

Nu Skin Enterprises, Inc. - NUS STOCK NEWS

Welcome to our dedicated news page for Nu Skin Enterprises (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enterprises.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nu Skin Enterprises's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nu Skin Enterprises's position in the market.

Rhea-AI Summary
Nu Skin Enterprises, Inc. (NUS) will release its first quarter 2024 results on May 8, followed by a conference call to discuss recent results and upcoming business initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
-
Rhea-AI Summary
Nu Skin Enterprises introduces Nu Skin RenuSpa iO, a smart beauty and wellness device using adaptive microcurrent technology for skin stimulation. The device aims to restore, revitalize, and refresh the body, providing visible beauty benefits and comprehensive wellness benefits. The FDA-cleared device makes real-time adjustments, offering personalized at-home experiences. Clinical testing showed improvements in skin depuffing, toning, and sculpting. RenuSpa iO is available in the U.S. for $375.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
none
-
Rhea-AI Summary
Nu Skin Enterprises Inc. (NYSE: NUS) announces Q4 2023 results slightly above guidance, with revenue at $488.6 million and EPS at $0.15. The company plans to focus on Rhyz growth, new market expansion, and digital affiliate platform. Q1 and FY 2024 outlook projects revenue decline and negative EPS due to macroeconomic challenges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.71%
Tags
Rhea-AI Summary
Nu Skin Enterprises Inc. (NYSE: NUS) announced Q4 preliminary revenue slightly above guidance, driven by the launch of ageLOC WellSpa iO, seasonal promotions in China, and continued performance of Rhyz. President and CEO Ryan Napierski and CFO James D. Thomas will present at the ICR Conference on Jan. 9, with full financial results to be announced on Feb. 14.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
none
-
Rhea-AI Summary
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced the opening of a new $55 million manufacturing facility in Shanghai, China. The facility, developed with Industry 4.0 standards in mind, quadruples the production capacity for Nu Skin in China and other Asian markets. The 440,000 square feet facility was designed to conserve energy and reduce water consumption, representing a significant commitment to China as a key R&D and manufacturing center for the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
none
-
Rhea-AI Summary
Nu Skin Enterprises Inc. (NYSE: NUS) reported third quarter 2023 results with revenue of $498.8 million, a decrease of 7% compared to the prior-year quarter. The company's earnings per share (EPS) were $(0.74), or $0.56 excluding an inventory write-off. Nu Skin experienced challenges in key markets, including Mainland China and the Americas, due to macro-economic factors and a strong U.S. dollar. However, the company saw modest growth in three reporting segments, including double-digit gains in Europe/Africa. Nu Skin is re-evaluating aspects of its business, such as its product portfolio and operational footprint, to drive long-term success. The company also announced the introduction of a new mental wellness category in 2024. Nu Skin's Q4 2023 revenue is projected to be $440 to $480 million, with an expected EPS of $(0.14) to $0.01 or $0.15 to $0.30 non-GAAP.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.45%
Tags
Rhea-AI Summary
Nu Skin Enterprises, Inc. declares a quarterly cash dividend of $0.39 per share. The dividend will be paid on Dec. 6, 2023, to shareholders of record on Nov. 24, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.45%
Tags
dividends
-
Rhea-AI Summary
Nu Skin Enterprises to release Q3 2023 results on Nov. 1, with a conference call at 5 p.m. ET. Webcast available on ir.nuskin.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
-
Rhea-AI Summary
Nu Skin ranked world’s No. 1 brand for beauty device systems for six consecutive years by Euromonitor International.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
Rhea-AI Summary
Nu Skin Enterprises, Inc. (NYSE: NUS) announced second quarter 2023 results, reporting a revenue of $500.3 million, a decrease of 11% from the prior-year quarter. Earnings Per Share (EPS) stood at $0.54 compared to $0.67, with 1,041,118 customers and 187,652 paid affiliates. Despite macro-economic challenges, the company is optimistic about its Nu Vision 2025 strategy and plans to roll out new products and incentives to drive growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
Nu Skin Enterprises, Inc.

NYSE:NUS

NUS Rankings

NUS Stock Data

595.52M
48.16M
1.7%
85.46%
2.87%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
US
Provo

About NUS

founded 35 years ago, nu skin enterprises, inc. (nse) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies, and life-improving values. the company currently focuses its efforts around innovative consumer products, product manufacturing and automated controlled environment agriculture technology. the nse family of companies includes: nu skin, groviv, wasatch labs, elevate health sciences, and casepak. nu skin enterprises is traded on the new york stock exchange under the symbol "nus." more information is available at nuskinenterprises.com.